Delivery Order SPE2DB22D1017-SPE2DB24FG2RJ

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.64 Firm Fixed Price Delivery Order is for the supply of SIMBRINZA 1%-0.2% eye drops, 8 ml, and has an ultimate completion date of June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,123.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with an ultimate completion date of January 23, 2025. The contract is a delivery order with a firm fixed price, and it is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,427.17 firm-fixed-price delivery order is for the supply of SIMBRINZA 1%-0.2% eye drops (8 ml) and has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, with ID SPE2DX15D3201|SPE2DX24F3H9Q, was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,252.77 firm fixed-price delivery order is for the supply of 4565778913 SIMBRINZA 1%-0.2% eye drops (8 mL) to support military treatment facilities and federal healthcare programs. The contract has no set-aside designation and will be completed by September 13, 2024. Amerisourcebergen holds...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,117.10, is for the procurement of Simbrinza 1%-0.2% eye drops, a medical product used in the treatment of various eye conditions. The contract has an ultimate completion date of April 19, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite...
This federal contract award, SPE2DB20D3101|SPE2DB25FRDY7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.12 firm fixed-price delivery order is for the supply of SIMBRINZA 1%-0.2% eye drops, a medical product used in eye care. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Simbrinza 1%-0.2% eye drops in 8 ml bottles. The contract has a ceiling value of $1,812.28 and an ultimate completion date of October 24, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,901.38 delivery order contract is for the supply of SIMBRINZA 1%-0.2% eye drops, a medical product used in the treatment of ocular conditions. The contract has a period of performance through May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This federal contract award is for the delivery of SIMBRINZA 1%-0.2% eye drops, valued at $1,248.50, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which is a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of November 6, 2023 and was awarded on November 3, 2023 under a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,759.58 firm fixed price contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a completion date of April 26, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB24FG2RJ
    Delivery Order

This federal contract award, valued at $1,126.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the supply of SIMBRINZA 1%-0.2% eye drops, a prescription ophthalmic medication. The award has a firm fixed price and an ultimate completion date of August 7, 2024. There is no set-aside designation for this contract.

Generated 11/5/24, 9:25 AM